Perjeta 420mg Injection
Marketer
Roche Products India Pvt Ltd
Salt Composition
Pertuzumab (30mg/ml)
Overview Perjeta 420mg Injection
Trastuzumab emtansine 420mg injection is a breast cancer treatment, classified as a monoclonal antibody. Administered intravenously under medical supervision, dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to your doctor's instructions is crucial, as improper usage or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical guidance. Common side effects include hair loss, nausea, diarrhea, and fatigue. This medication can lower blood cell counts (particularly white blood cells), increasing infection risk. Regular blood tests, along with heart, liver, and kidney function monitoring, are necessary. Inform your healthcare provider about all other medications you are taking, as interactions are possible. Pregnancy and breastfeeding are contraindicated. Reliable contraception is essential for both partners during treatment. A patient assistance program, facilitated by Tata 1mg, is accessible in India; consult your doctor or call 1800-102-1618 for further information.
Primary Ingredients of Perjeta 420mg Injection
No text provided to rephrase.
Uses of Perjeta 420mg Injection
Malignant breast tumor
Major Benefits of Perjeta 420mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Perjeta 420mg Injection:
- Diarrhea
- Hair loss
- Feeling sick
- Rash
- Stomach inflammation
- Decreased blood cells (red cells, white cells, and platelets)
- Muscle pain
- Cough
- Heartburn
- Breathlessness
- Dizziness
- Fatigue
How to use Perjeta 420mg Injection:
Administering this medication will be done by your healthcare provider. Self-medication is strictly prohibited.
How Perjeta 420mg Injection works:
Perjeta's 420mg injection, a monoclonal antibody, targets specific proteins on cancerous cells. By binding to the human epidermal growth factor receptor 2 (HER2), this injection inhibits or eliminates the proliferation of these cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Perjeta 420mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Perjeta 420mg Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is advised.
Breast feedingUNSAFE
Breastfeeding is contraindicated during treatment with Perjeta 420mg Injection due to the potential for drug-induced infant toxicity.
DrivingCONSULT YOUR DOCTOR
The effect of Perjeta 420mg Injection on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Perjeta 420mg Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverCONSULT YOUR DOCTOR
Data regarding Perjeta 420mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Perjeta 420mg Injection :
NA
Facts to Know About Perjeta 420mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Monoclonal Antibody HER2/neu (ErbB2) Inhibitor |
3,018 People bought this recently